SPRY ARS Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$4,07
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,9952-Wochen-Tief
$13,1552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$405M
P/E (TTM)
-1.9
EPS (TTM)
$-2.17
Umsatz (TTM)
$117M
Ihre Abzeichen
52W-Spanne
$4–$13
Analystenbewertung
STRONG BUY
Kursziel
$22
P/E
-1.9
ROE
-210.3%
Nettogewinnmarge
-184.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SPRY Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.07
Marktkapitalisierung (MRQ)
$405M
P/E (TTM)
-1.9
EPS (TTM)
$-2.17
Umsatz (TTM)
$117M
ROE (TTM)
-210.3%
52W-Spanne
$4–$13
SPRY Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über ARS Pharmaceuticals, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter195
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$84M2021-12-31 → 2025-12-31
EPS$-1.742021-12-31 → 2025-12-31
Freier Cashflow$-171M2021-12-31 → 2025-12-31
Nettogewinnmarge-184.2%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SPRY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.95-Jahres-Durchschnitt ≈19.2 | ≈19.2 | · | · | |
| P/S (TTM) | 3.55-Jahres-Durchschnitt ≈3657.7 | ≈3657.7 | · | · | |
| K/B (MRQ) | 32.35-Jahres-Durchschnitt ≈4.0 | ≈4.0 | 3.1 | Überbewertet | |
| Kurs / FCF (TTM) | -2.15-Jahres-Durchschnitt ≈8.1 | ≈8.1 | · | · | |
| Kurs / Cashflow (TTM) | -2.15-Jahres-Durchschnitt ≈7.4 | ≈7.4 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -291.65-Jahres-Durchschnitt ≈5.2 | ≈5.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SPRY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -185.0%5-Jahres-Durchschnitt ≈-62499.0% | ≈-62499.0% | -115.0% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -212.9%5-Jahres-Durchschnitt ≈-62494.2% | ≈-62494.2% | -115.0% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -203.4% | · | · | · | |
| Nettogewinnmarge (TTM) | -184.2%5-Jahres-Durchschnitt ≈-53691.9% | ≈-53691.9% | -107.0% | Schwach | |
| ROA (TTM) | -76.5%5-Jahres-Durchschnitt ≈-22.7% | ≈-22.7% | -50.5% | Im Einklang | |
| ROE (TTM) | -210.3%5-Jahres-Durchschnitt ≈-38.1% | ≈-38.1% | -77.4% | Schwach | |
| ROIC | -157.0% | · | -61.4% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SPRY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.55-Jahres-Durchschnitt ≈37.4 | ≈37.4 | 9.4 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 3.15-Jahres-Durchschnitt ≈36.7 | ≈36.7 | 7.7 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | SPRY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -5.5%5-Jahres-Durchschnitt ≈74221.0% | ≈74221.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 300.1% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | SPRY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.25-Jahres-Durchschnitt ≈0.1 | ≈0.1 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 5.0 | · | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$432.2K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-5.9%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $-0.63 | $-0.50 | -25.4% |
| 31. März 2026 | Mai 15, 2026 | $-0.61 | $-0.54 | -13.8% |
| 31. Dezember 2025 | $-0.42 | $-0.45 | 6.8% | |
| 30. September 2025 | $-0.52 | $-0.48 | -8.0% | |
| 30. Juni 2025 | $-0.46 | $-0.48 | 4.0% | |
| 31. März 2025 | $-0.35 | $-0.35 | 1.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $84M | $89M | $30.0K | $1M | $6M | |
| Cost of Revenue | · | · | $0 | · | · | |
| R&D Expense | $13M | $20M | $20M | $18M | $20M | |
| SG&A Expense | $230M | $72M | $47M | $603.0K | $5M | |
| Operating Expenses | $264M | $92M | $68M | $37M | $25M | |
| Operating Income | $-179M | $-3M | $-68M | $-36M | $-19M | |
| Other Non-op | $8M | $11M | $13M | $974.0K | $-789.0K | |
| Pretax Income | $-171M | $8M | $-54M | · | · | |
| Income Tax | $-80.0K | $288.0K | $0 | $0 | $0 | |
| Net Income | $-171M | $8M | $-54M | $-35M | $-20M | |
| EPS (Basic) | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 | |
| EPS (Diluted) | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 | |
| Shares (Basic) | 98,566,481 | 96,936,661 | 95,215,322 | 39,956,043 | 28,872,242 | |
| Shares (Diluted) | 98,566,481 | 102,390,828 | 95,215,322 | 39,956,043 | 28,872,242 | |
| EBITDA | $-179M | $-3M | $-68M | $-35M | $-90M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $51M | $71M | $211M | $60M | |
| Short-term Investments | $204M | $263M | $157M | $64M | $0 | |
| Receivables | $25M | $8M | $0 | · | · | |
| Inventory | $31M | $11M | $0 | · | · | |
| Prepaid Expense | $6M | $7M | $3M | $3M | $667.0K | |
| Current Assets | $285M | $334M | $232M | $278M | $61M | |
| PP&E (Net) | $2M | $1M | $574.0K | $329.0K | $72.0K | |
| PP&E (Gross) | · | · | $695.0K | $377.0K | $86.0K | |
| Accum. Depreciation | · | $200.0K | $121.0K | $48.0K | $14.0K | |
| Intangibles | $14M | $7M | $0 | · | · | |
| Other Non-current Assets | · | · | · | $0 | · | |
| Total Assets | $328M | $351M | $233M | $281M | $61M | |
| Accounts Payable | $6M | $10M | $759.0K | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | $12M | |
| Short-term Debt | · | · | · | $0 | $3M | |
| Current Liabilities | $39M | $23M | $2M | $5M | $8M | |
| Capital Leases | · | $0 | $37.0K | $251.0K | $480.0K | |
| Total Liabilities | $213M | $94M | $2M | $9M | $17M | |
| Long-term Debt | $96M | $0 | · | · | · | |
| Total Debt | · | · | · | $0 | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $9.0K | $3.0K | |
| Paid-in Capital | $409M | $380M | $362M | $349M | $11M | |
| Retained Earnings | $-295M | $-123M | $-131M | $-77M | $-42M | |
| AOCI | $125.0K | $220.0K | $49.0K | $407.0K | $0 | |
| Stockholders' Equity | $114M | $257M | $231M | $273M | $-31M | |
| Liabilities + Equity | $328M | $351M | $233M | $281M | $61M | |
| Shares Outstanding | 99,290,926 | 97,954,172 | 96,414,963 | 93,943,316 | 30,369,413 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $1M | $79.0K | $100.0K | $319.0K | $213.0K | |
| Stock-based Comp | $22M | $15M | $9M | $6M | $3M | |
| Deferred Tax | $0 | $0 | $0 | · | · | |
| Amort. of Intangibles | $800.0K | $100.0K | · | · | · | |
| Other Non-cash | · | · | · | $-12M | · | |
| Operating Cash Flow | $-171M | $14M | $-59M | $-40M | $-18M | |
| CapEx | $339.0K | $563.0K | $175.0K | $199.0K | $55.0K | |
| Investing Cash Flow | $57M | $-106M | $-87M | $-199.0K | $-55.0K | |
| Financing Cash Flow | $105M | $72M | $7M | $191M | $53M | |
| Net Change in Cash | $-10M | $-20M | $-140M | $150M | $36M | |
| Taxes Paid | $200.0K | · | · | · | · | |
| Free Cash Flow | $-171M | $13M | $-59M | $-40M | $-68M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -212.9% | -3.5% | -225066.7% | -2698.8% | -84513.2% | |
| Net Margin | -203.3% | 9.0% | -181216.7% | -2635.4% | -84413.2% | |
| Pretax Margin | -203.4% | 9.3% | · | · | · | |
| EBITDA Margin | -212.9% | -3.5% | -225066.7% | -2674.5% | -84513.2% | |
| ROA | -50.5% | 2.7% | -21.1% | -20.2% | -24.6% | |
| ROE | -111.8% | 3.5% | -23.2% | -31.1% | -27.7% | |
| ROIC | -157.0% | -1.2% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 14.3 | 96.9 | 51.0 | 17.6 | |
| Quick Ratio | 6.9 | 13.7 | 95.5 | 50.4 | 17.1 | |
| Debt / Equity | · | · | · | 0.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 5.0 | 21.8 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $1.15 | $2.62 | $2.39 | $2.90 | $8.94 | |
| Revenue / Share | $0.85 | $0.87 | $0.00 | $0.03 | · | |
| Cash Flow / Share | $-1.73 | $0.13 | $-0.62 | $-1.00 | · | |
| Cash / Share | $0.42 | $0.52 | $0.74 | $2.24 | $7.24 | |
| EPS (TTM) | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | -5.5% | 297063.3% | -97.7% | -76.1% | · | |
| Revenue CAGR 3Y | 300.1% | 153.0% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $84M | $89M | $30.0K | $1M | $6M | |
| Net Income TTM | $-171M | $8M | $-54M | $-35M | $-20M | |
| Market Cap | $1.16B | $1.03B | $528M | $801M | $234M | |
| Enterprise Value | · | · | · | $527M | · | |
| P/E | -6.7 | 131.9 | -9.6 | -9.8 | -9.5 | |
| P/S | 13.7 | 11.6 | 17611.8 | 608.9 | 42.5 | |
| P/B | 10.1 | 4.0 | 2.3 | 2.9 | 0.7 | |
| P / Tangible Book | 11.6 | 4.1 | 2.3 | 2.9 | · | |
| P / Cash Flow | -6.8 | 76.3 | -8.9 | -20.0 | -3.5 | |
| P / FCF | -6.8 | 79.6 | -8.9 | -19.9 | -3.4 | |
| EV / EBITDA | · | · | · | -15.0 | · | |
| EV / FCF | · | · | · | -13.1 | · | |
| EV / Revenue | · | · | · | 400.4 | · | |
| Earnings Yield | -14.9% | 0.76% | -10.4% | -10.2% | -10.5% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34M | $23M | $28M | $33M | $16M | $8M | $87M | $2M | $500.0K | $0 | $0 | $0 | $10.0K | $20.0K | $0 | $189.0K | |
| R&D Expense | $5M | $4M | $3M | $3M | $4M | $3M | $3M | $4M | $7M | $5M | $3M | $3M | $7M | $7M | $5M | $4M | |
| SG&A Expense | $78M | $72M | $60M | $75M | $54M | $41M | $35M | $19M | $9M | $8M | $32M | $15M | $181.0K | $337.0K | $-7M | $3M | |
| Operating Expenses | $95M | $83M | $70M | $86M | $63M | $45M | $39M | $24M | $16M | $13M | $10M | $18M | $21M | $19M | $15M | $7M | |
| Operating Income | $-61M | $-60M | $-41M | $-53M | $-48M | $-37M | $47M | $-22M | $-15M | $-13M | $-10M | $-18M | $-21M | $-19M | $-15M | $-7M | |
| Other Non-op | $-874.0K | $-473.0K | $61.0K | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $1M | $47.0K | |
| Net Income | $-62M | $-61M | $-41M | $-51M | $-45M | $-34M | $50M | $-19M | $-13M | $-10M | $-7M | $-15M | $-17M | $-15M | $-14M | $-7M | |
| EPS (Basic) | $-0.63 | $-0.61 | $-0.41 | $-0.52 | $-0.46 | $-0.35 | $0.52 | $-0.20 | $-0.13 | $-0.11 | $-0.07 | $-0.16 | $-0.18 | $-0.16 | $-0.21 | $-0.21 | |
| EPS (Diluted) | $-0.63 | $-0.61 | $-0.41 | $-0.52 | $-0.46 | $-0.35 | $0.52 | $-0.20 | $-0.13 | $-0.11 | $-0.07 | $-0.16 | $-0.18 | $-0.16 | $-0.21 | $-0.21 | |
| Shares (Basic) | 99,312,526 | 99,296,408 | · | 98,807,600 | 98,361,771 | 98,060,636 | · | 97,032,331 | 96,827,687 | 96,486,480 | · | 95,576,627 | 94,911,268 | 94,227,313 | · | 30,755,123 | |
| Shares (Diluted) | 99,312,526 | 99,296,408 | · | 98,807,600 | 98,361,771 | 98,060,636 | · | 97,032,331 | 96,827,687 | 96,486,480 | · | 95,576,627 | 94,911,268 | 94,227,313 | · | 30,755,123 | |
| EBITDA | $-61M | · | · | $-53M | $-48M | $-37M | · | · | $-15M | $-13M | · | $-18M | $-21M | $-19M | · | $-19M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $24M | $41M | $60M | $52M | $40M | $51M | $40M | $37M | $56M | $71M | $61M | $119M | $88M | $211M | $203M | |
| Short-term Investments | $136M | $177M | $204M | $229M | $189M | $236M | $263M | $165M | $182M | $168M | $157M | $181M | $133M | $177M | $64M | $63M | |
| Receivables | $47M | $29M | $25M | $36M | $25M | $9M | $8M | $773.0K | · | · | $0 | · | · | · | · | · | |
| Inventory | $31M | $32M | $31M | $21M | $22M | $7M | $11M | $715.0K | · | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $9M | $7M | $6M | $6M | $7M | $12M | $7M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | |
| Current Assets | $212M | $245M | $285M | $339M | $281M | $304M | $334M | $209M | $221M | $226M | $232M | $244M | $255M | $267M | $278M | $271M | |
| PP&E (Net) | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $843.0K | $636.0K | $616.0K | $574.0K | $617.0K | $594.0K | $584.0K | $329.0K | $15.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $748.0K | · | $726.0K | $682.0K | $652.0K | $377.0K | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | $171.0K | $150.0K | $132.0K | $121.0K | $109.0K | $88.0K | $68.0K | $48.0K | · | |
| Intangibles | $14M | $14M | $14M | $15M | $13M | $7M | $7M | $8M | · | · | $0 | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $690.0K | $138.0K | · | · | · | |
| Total Assets | $249M | $288M | $328M | $373M | $313M | $327M | $351M | $218M | $222M | $228M | $233M | $249M | $259M | $271M | $281M | $271M | |
| Accounts Payable | $5M | $5M | $6M | $8M | $16M | $4M | $10M | $8M | $3M | $839.0K | $759.0K | $3M | $2M | $3M | $2M | $126.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Current Liabilities | $61M | $50M | $39M | $51M | $46M | $28M | $23M | $17M | $7M | $4M | $2M | $11M | $10M | $10M | $5M | $4M | |
| Capital Leases | · | · | · | $949.0K | $1M | · | · | $0 | $0 | $0 | $37.0K | $92.0K | $146.0K | $199.0K | $251.0K | $0 | |
| Total Liabilities | $237M | $226M | $213M | $225M | $121M | $98M | $94M | $17M | $7M | $4M | $2M | $11M | $10M | $10M | $9M | $4M | |
| Long-term Debt | $97M | $97M | $96M | $96M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $4.0K | |
| Paid-in Capital | $430M | $417M | $409M | $401M | $394M | $386M | $380M | $374M | $369M | $366M | $362M | $362M | $358M | $353M | $349M | $517M | |
| Retained Earnings | $-418M | $-355M | $-295M | $-253M | $-202M | $-157M | $-123M | $-173M | $-154M | $-142M | $-131M | $-124M | $-109M | $-92M | $-77M | $-248M | |
| AOCI | $-140.0K | $-96.0K | $125.0K | $-7.0K | $-46.0K | $72.0K | $220.0K | $339.0K | $-145.0K | $-124.0K | $49.0K | $-161.0K | $-180.0K | $68.0K | $407.0K | $-2M | |
| Stockholders' Equity | $13M | $61M | $114M | $148M | $192M | $229M | $257M | $201M | $215M | $224M | $231M | $237M | $249M | $261M | $273M | $267M | |
| Liabilities + Equity | $249M | $288M | $328M | $373M | $313M | $327M | $351M | $218M | $222M | $228M | $233M | $249M | $259M | $271M | $281M | $271M | |
| Shares Outstanding | 99,437,865 | 99,300,137 | 99,290,926 | 98,844,178 | 98,697,658 | 98,129,804 | 97,954,172 | 97,147,442 | 96,939,797 | 96,574,049 | 96,414,963 | 95,796,254 | 95,322,953 | 94,448,028 | 93,943,316 | 35,882,653 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $416.0K | $397.0K | $417.0K | $391.0K | $279.0K | $280.0K | $29.0K | $100.0K | $18.0K | $11.0K | $0 | $100.0K | · | · | · | · | |
| Stock-based Comp | $12M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $2M | $3M | $2M | $2M | $5M | $-9M | |
| Amort. of Intangibles | $300.0K | $300.0K | $499.9K | $200.0K | $100.0K | $100.0K | $100.0K | $0 | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $-61M | $-45M | $-43M | $-47M | $-40M | $-41M | $42M | $-14M | $-7M | $-7M | $-17M | $-13M | $-17M | $-12M | $-20M | $15M | |
| CapEx | $0 | $0 | $0 | $197.0K | $51.0K | $91.0K | $302.0K | $140.0K | $38.0K | $83.0K | $-91.0K | $43.0K | $30.0K | $193.0K | $126.0K | $-545.0K | |
| Investing Cash Flow | $42M | $28M | $24M | $-45M | $49M | $29M | $-102M | $17M | $-13M | $-9M | $26M | $-47M | $45M | $-112M | $-126.0K | $545.0K | |
| Financing Cash Flow | $3M | $159.0K | $1M | $100M | $3M | $725.0K | $71M | $680.0K | $545.0K | $258.0K | $2M | $921.0K | $3M | $1M | $194M | $-3M | |
| Net Change in Cash | $-16M | $-17M | $-18M | $8M | $12M | $-11M | $11M | $3M | $-19M | $-15M | $10M | $-58M | $31M | $-123M | $173M | $-7M | |
| Free Cash Flow | · | · | · | · | · | $-41M | · | · | · | $-7M | · | · | · | $-13M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -182.6% | · | · | -163.7% | -302.9% | -466.3% | · | · | -3068.0% | · | · | · | -206030.0% | -93565.0% | · | -1761.8% | |
| Net Margin | -185.2% | · | · | -157.4% | -285.6% | -425.7% | · | · | -2503.2% | · | · | · | -173700.0% | -74805.0% | · | -1661.8% | |
| EBITDA Margin | -182.6% | · | · | -163.7% | -302.9% | -466.3% | · | · | -3068.0% | · | · | · | -206030.0% | -93565.0% | · | -1761.8% | |
| ROA | -22.1% | · | · | -17.3% | -16.8% | -12.2% | · | · | -5.2% | -4.1% | · | -5.7% | -6.3% | -5.1% | · | -5.7% | |
| ROE | -60.9% | · | · | -29.3% | -22.0% | -15.0% | · | · | -5.4% | -4.2% | · | -5.9% | -6.6% | -5.4% | · | -6.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | · | · | 6.7 | 6.2 | 11.0 | · | · | 32.8 | 60.9 | · | 21.9 | 25.4 | 27.2 | · | 67.9 | |
| Quick Ratio | 3.1 | · | · | 6.4 | 5.8 | 10.3 | · | · | 32.5 | 60.2 | · | 21.6 | 25.1 | 26.9 | · | 66.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.1 | 0.0 | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 0.9 | · | · | 1.7 | 1.3 | 1.7 | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.13 | · | · | $1.49 | $1.95 | $2.33 | · | · | $2.22 | $2.32 | · | $2.48 | $2.61 | $2.77 | · | $7.44 | |
| Revenue / Share | $0.34 | · | · | $0.33 | $0.16 | $0.08 | · | · | $0.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.03 | |
| Cash Flow / Share | · | · | · | · | · | $-0.42 | · | · | · | $-0.07 | · | · | · | $-0.13 | · | · | |
| Cash / Share | $0.08 | · | · | $0.60 | $0.52 | $0.41 | · | · | $0.38 | $0.58 | · | $0.63 | $1.25 | $0.93 | · | $5.66 | |
| EPS (TTM) | $-2.17 | $-1.94 | · | $-0.81 | $-0.49 | $-0.16 | · | $-0.60 | $-0.47 | $-0.52 | · | $-0.71 | $-0.76 | $-0.79 | · | $0.53 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $79M | · | $143M | $112M | $97M | · | $3M | $500.0K | $10.0K | · | $30.0K | $219.0K | $673.0K | · | · | |
| Net Income TTM | $-215M | $-191M | · | $-80M | $-48M | $-16M | · | $-57M | $-45M | $-50M | · | $-62M | $-53M | $-42M | · | $26M | |
| Market Cap | $796M | · | · | $993M | $1.72B | $1.23B | · | · | $825M | $987M | · | $362M | $639M | $615M | · | $189M | |
| P/E | -3.7 | -4.1 | · | -12.4 | -35.6 | -78.6 | · | -24.2 | -18.1 | -19.7 | · | -5.3 | -8.8 | -8.2 | · | 10.0 | |
| P/S | 6.8 | · | · | 7.0 | 15.3 | 12.7 | · | · | 1649.9 | 98698.7 | · | 12070.3 | 2916.3 | 913.6 | · | · | |
| P/B | 63.7 | · | · | 6.7 | 9.0 | 5.4 | · | · | 3.8 | 4.4 | · | 1.5 | 2.6 | 2.4 | · | 0.7 | |
| P / Tangible Book | · | 16.9 | · | 7.5 | 9.6 | 5.6 | · | 7.3 | 3.8 | 4.4 | · | 1.5 | 2.6 | 2.4 | · | 0.7 | |
| P / Cash Flow | · | · | · | · | · | -30.3 | · | · | · | -147.1 | · | · | · | -49.5 | · | · | |
| Earnings Yield | -27.1% | -24.2% | · | -8.1% | -2.8% | -1.3% | · | -4.1% | -5.5% | -5.1% | · | -18.8% | -11.3% | -12.1% | · | 10.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $84M | $89M | $30.0K | $1M | $6M |
| Betriebsgewinnmarge % | -212.9% | -3.5% | -225066.7% | -2698.8% | -84513.2% |
| Nettoergebnis | $-171M | $8M | $-54M | $-35M | $-20M |
| Verwässerte EPS | $-1.74 | $0.08 | $-0.57 | $-0.87 | $-0.70 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | · | 0.0 | · |
| Liquiditätsgrad | 7.3 | 14.3 | 96.9 | 51.0 | 17.6 |
| Quick Ratio | 6.9 | 13.7 | 95.5 | 50.4 | 17.1 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-171M | $13M | $-59M | $-40M | $-68M |
Institutionelle Eigentümer (13F) 222 Einreicher · $746.7M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
222
Gehaltener Wert
$746.7M
Neue Positionen
38
Geschlossene Positionen
30
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 38 (-5 vs. Vorquartal) | 30 (+7 vs. Vorquartal) | 73 (+10 vs. Vorquartal) | 56 (0 vs. Vorquartal) | -4.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $86.996.426 | 10.860.977 | 11,65% | Aktien |
| Rubric Capital Management LP | $68.412.297 | 8.540.861 | 9,16% | Aktien |
| ORBIMED ADVISORS LLC | $66.390.965 | 8.288.510 | 8,89% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $60.105.534 | 7.503.812 | 8,05% | Aktien |
| BlackRock, Inc. | $42.543.666 | 5.311.319 | 5,70% | Aktien |
| VANGUARD GROUP INC | $40.881.877 | 3.509.174 | 5,48% | Aktien |
| Tyro Capital Management LLC | $35.719.289 | 4.459.337 | 4,78% | Aktien |
| Aberdeen Group plc | $33.406.738 | 4.170.629 | 4,47% | Aktien |
| SR One Capital Management, LP | $32.143.353 | 4.012.903 | 4,30% | Aktien |
| STATE STREET CORP | $29.882.290 | 3.730.623 | 4,00% | Aktien |
| Capital World Investors | $22.066.997 | 2.754.931 | 2,96% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $20.453.759 | 2.553.528 | 2,74% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $19.231.505 | 2.400.937 | 2,58% | Aktien |
| UBS Group AG | $15.536.629 | 1.939.654 | 2,08% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $13.612.279 | 1.699.017 | 1,82% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $12.828.047 | 1.601.504 | 1,72% | Aktien |
| GENERAL AMERICAN INVESTORS CO INC | $9.075.698 | 1.133.046 | 1,22% | Aktien |
| Third Point LLC | $8.010.000 | 1.000.000 | 1,07% | Aktien |
| PEREGRINE CAPITAL MANAGEMENT LLC | $5.383.833 | 672.139 | 0,72% | Aktien |
| Tejara Capital Ltd | $4.862.382 | 607.039 | 0,65% | Aktien |
| ADAR1 Capital Management, LLC | $4.814.002 | 600.999 | 0,64% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.540.300 | 566.829 | 0,61% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.416.842 | 551.416 | 0,59% | Aktien |
| NORTHERN TRUST CORP | $4.398.003 | 549.064 | 0,59% | Aktien |
| LEVIN CAPITAL STRATEGIES, L.P. | $4.397.210 | 548.965 | 0,59% | Aktien |
| CITADEL ADVISORS LLC | $4.253.814 | 531.063 | 0,57% | Aktien |
| Empire Life Investments Inc. | $3.779.567 | 471.856 | 0,51% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3.731.388 | 464.681 | 0,50% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.710.681 | 463.256 | 0,50% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.692.618 | 461.001 | 0,49% | Aktien |
| FIL Ltd | $3.649.156 | 455.575 | 0,49% | Aktien |
| JPMORGAN CHASE & CO | $3.109.986 | 363.316 | 0,42% | Aktien |
| GOLDMAN SACHS GROUP INC | $3.049.967 | 380.770 | 0,41% | Aktien |
| Eversept Partners, LP | $3.019.826 | 377.007 | 0,40% | Aktien |
| K2 PRINCIPAL FUND, L.P. | $3.004.807 | 375.132 | 0,40% | Aktien |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $2.991.663 | 373.491 | 0,40% | Aktien |
| FMR LLC | $2.796.806 | 349.164 | 0,37% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $2.551.850 | 318.583 | 0,34% | Aktien |
| Trexquant Investment LP | $2.296.731 | 286.733 | 0,31% | Aktien |
| Jump Financial, LLC | $2.044.152 | 255.200 | 0,27% | Aktien |
| MORGAN STANLEY | $1.835.091 | 229.100 | 0,25% | Aktien |
| FAS Wealth Partners, Inc. | $1.718.202 | 214.507 | 0,23% | Aktien |
| Quinn Opportunity Partners LLC | $1.401.750 | 175.000 | 0,19% | Aktien |
| Bank of New York Mellon Corp | $1.346.769 | 168.136 | 0,18% | Aktien |
| DAFNA Capital Management LLC | $1.315.923 | 164.285 | 0,18% | Aktien |
| Nuveen, LLC | $1.292.350 | 161.342 | 0,17% | Aktien |
| Ishara Investments LP | $1.149.355 | 143.490 | 0,15% | Aktien |
| Engineers Gate Manager LP | $1.116.746 | 139.419 | 0,15% | Aktien |
| Steward Partners Investment Advisory, LLC | $1.030.086 | 128.600 | 0,14% | Aktien |
| BARCLAYS PLC | $1.011.352 | 126.261 | 0,14% | Aktien |
Aktivisten & 5%+-Eigentümer 8 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×4 Einreichungen | 1. Oktober 2025 | 11,10% | Änderung | · | SEC |
| Deerfield Mgmt III, L.P., Deerfield Private Design Fund III, L.P., Deerfield Mgmt IV, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×5 Einreichungen | 1. August 2025 | 7,75% | Änderung | · | SEC |
| The Pratik Shah Living Trust dated June 15, 2011(1) ×3 Einreichungen | 17. Juni 2024 | · | Erste Einreichung | · | SEC |
| Robert G. Bell ×2 Einreichungen | 1. September 2023 | · | Erste Einreichung | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital LLC ×2 Einreichungen | 30. November 2022 | · | Erste Einreichung | · | SEC |
| Richard E. Lowenthal, M.S., MSEL | 18. November 2022 | · | Erste Einreichung | · | SEC |
| Sarina Tanimoto, M.D., M.B.A. | 18. November 2022 | · | Erste Einreichung | · | SEC |
| U.S. Venture Partners XII, L.P. (“USVP XII”), U.S. Venture Partners XII-A, L.P. (“USVP XII-A”), Presidio Management Group XII, L.L.C. (“PMG XII”), Casey M. Tansey, Jonathan D. Root ×2 Einreichungen | 27. Januar 2022 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 28 Insider · 11 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kathleen D. Scott | Chief Financial Officer | 2. Januar 2026 A | 10.042 | 0 | 0 | $0 |
| Jonathan Piazza | Chief Financial Officer | 2. Mai 2022 A | 69.225 | 0 | 0 | $0 |
| Donn Casale | President | 1. Juli 2026 A | · | 0 | 0 | $0 |
| Valerie Odegard | President and CSO | 2. Mai 2022 A | 61.639 | 0 | 0 | $0 |
| Margaret Ekins Smith | Chief Commercial Officer | 1. September 2026 A | · | 0 | 0 | $0 |
| Eric Karas | Chief Commercial Officer | 12. Juni 2026 M | 12.176 | 0 | 1 | $-250.000 |
| Alexander A Fitzpatrick | Chief Legal Officer | 12. Juni 2026 S | 90.910 | 0 | 1 | $-33.550 |
| Sarina Tanimoto | CHIEF MEDICAL OFFICER | 2. Januar 2026 A | 1.247.447 | 0 | 0 | $0 |
| Justin Chakma | Chief Business Officer | 2. Januar 2026 A | 0 | 0 | 2 | $-1.475.627 |
| Naomi Hunder | Chief Medical Officer | 2. Mai 2022 A | 54.427 | 0 | 0 | $0 |
| Russ Hawkinson | Sr. Vice President of Finance | 2. Mai 2022 A | 37.251 | 0 | 0 | $0 |
| Michael Kelly | Direktor | 24. Juni 2026 A | 83.225 | 0 | 0 | $0 |
| Rajeev Dadoo | Direktor | 24. Juni 2026 A | 3.009.677 | 0 | 0 | $0 |
| Pratik Shah | Direktor | 24. Juni 2026 A | 4.474.554 | 0 | 0 | $0 |
| Saqib Islam | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Laura Shawver | Direktor | 24. Juni 2026 A | 210.346 | 0 | 0 | $0 |
| Peter A. Thompson | Direktor | 24. Juni 2026 A | 0 | 0 | 0 | $0 |
| Brent L Saunders | Direktor | 24. Juni 2026 A | 0 | 0 | 0 | $0 |
| Phillip M Schneider | Direktor | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Maria Koehler | Direktor | 10. Juni 2022 A | · | 0 | 0 | $0 |
| Andrew Kenneth William Powell | Direktor | 10. Juni 2022 A | · | 0 | 0 | $0 |
| Robert Hershberg | Direktor | 10. Juni 2022 A | · | 0 | 0 | $0 |
| Vickie L Capps | Direktor | 10. Juni 2022 A | 61.576 | 0 | 0 | $0 |
| Jonathan D Root | Direktor | 10. Juni 2022 A | 2.364 | 0 | 0 | $0 |
| Thilo Schroeder | Direktor | 8. Dezember 2020 C | 1.910.029 | 0 | 0 | $0 |
| Alexandria Venture Investments, LLC | 10%-Eigentümer | 8. Dezember 2020 C | 699.412 | 0 | 0 | $0 |
| Brian Dorsey | · | 2. Januar 2026 A | 10.789 | 0 | 1 | $-190.122 |
| Richard E Lowenthal | · | 2. Januar 2026 A | 1.196.494 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 23 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,08% | 77.714 NS | 31. Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,05% | 3.668 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 66.043 SH | 19. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 7.035 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,02% | 471.221 SH | 11. September 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,02% | 1.062 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,02% | 578.426 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.579.276 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 29.426 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 745.809 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 354.157 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 142.140 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 22.392 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2.851 SH | 10. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 39.569 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 2.672 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 81.645 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 17.862 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.749.763 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.489 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.495 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 13.569 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 52.056 SH | 11. September 2026 | Täglich |
SPRY Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$22.50
+452,8%
5 50,0%
Starker Kauf
4 40,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-02Mittelwert-Ziel $22.50 +452,8%
← Unter allen Zielen
Aktueller Preis $4.07
Tief$15.00
Mittelwert$22.50
Hoch$30.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| EIKN | · | · | · | · | · | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| GALT | $271M | -8.7 | · | · | 25.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026